Introduction Stenotrophomonas maltophilia is a little-known environmental opportunistic
bacterium that can cause broad-spectrum infections. Despite the importance of this …

Objectives Stenotrophomonas maltophilia (S. maltophilia), an opportunistic pathogen,
causes infection in patients undergoing immunosuppressive therapy, mechanical …

Abstract Introduction Infections caused by Stenotrophomonas maltophilia are clinically
important due to its intrinsic resistance to a broad range of antibiotics. Therefore, selecting …

Stenotrophomonas maltophilia is a Gram-negative, biofilm-forming bacterium. Although
generally regarded as an organism of low virulence, S. maltophilia is an emerging multi …

Introduction: stenotrophomonas maltophilia is a clinically relevant opportunistic and
nosocomial pathogen with increasing concerns regarding antibiotic resistance. Accurate …

Stenotrophomonas maltophilia (SM) represents a challenging pathogen due to its resistance
profile. A systematic review of the available evidence was conducted to evaluate the best …

Stenotrophomonas maltophilia is a nonfermenting gram-negative bacterium associated with
multiple nosocomial outbreaks. Antibiotic resistance increases healthcare costs, disease …

Background Stenotrophomonas maltophilia is a cause of infection most commonly in the
opportunistic host. Trimethoprim-sulfamethoxazole and levofloxacin are considered first-line …

Objectives The historical treatment of choice for Stenotrophomonas maltophilia infection is
trimethoprim/sulfamethoxazole and this is primarily based on preclinical studies. The …

Background Stenotrophomonas maltophilia is inherently resistant to many antimicrobials. So
far, antimicrobial susceptibility tests for S. maltophilia have not been fully standardized. The …